226 related articles for article (PubMed ID: 16019441)
1. Angiogenesis and hematological malignancies.
Lim ST; Levine AM
Hematology; 2005 Feb; 10(1):11-24. PubMed ID: 16019441
[TBL] [Abstract][Full Text] [Related]
2. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
Hicklin DJ; Ellis LM
J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
4. Targeting the vascular endothelial growth factor in hematologic malignancies.
Paesler J; Gehrke I; Poll-Wolbeck SJ; Kreuzer KA
Eur J Haematol; 2012 Nov; 89(5):373-84. PubMed ID: 22928557
[TBL] [Abstract][Full Text] [Related]
5. [Neoplasms and angiogenesis].
Lewy-Trenda I
Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
[TBL] [Abstract][Full Text] [Related]
6. [Angiogenesis and hematologic malignancy].
Zini JM; Tobelem G
Bull Cancer; 2007 Jul; 94 Spec No():S241-6. PubMed ID: 17846010
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenesis in haematological malignancies.
Li WW; Hutnik M; Gehr G
Br J Haematol; 2008 Dec; 143(5):622-31. PubMed ID: 19036013
[TBL] [Abstract][Full Text] [Related]
8. A review on pro- and anti-angiogenic factors as targets of clinical intervention.
Bouïs D; Kusumanto Y; Meijer C; Mulder NH; Hospers GA
Pharmacol Res; 2006 Feb; 53(2):89-103. PubMed ID: 16321545
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibitors: a rational strategy for radiosensitization in the treatment of non-small-cell lung cancer?
Raben D; Helfrich B
Clin Lung Cancer; 2004 Jul; 6(1):48-57. PubMed ID: 15310417
[TBL] [Abstract][Full Text] [Related]
10. VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy.
Greenberg JI; Cheresh DA
Expert Opin Biol Ther; 2009 Nov; 9(11):1347-56. PubMed ID: 19761418
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and prostate cancer tumor growth.
Nicholson B; Theodorescu D
J Cell Biochem; 2004 Jan; 91(1):125-50. PubMed ID: 14689586
[TBL] [Abstract][Full Text] [Related]
12. BRN-103, a novel nicotinamide derivative, inhibits VEGF-induced angiogenesis and proliferation in human umbilical vein endothelial cells.
Choi HE; Yoo MS; Choi JH; Lee JY; Kim JH; Kim JH; Lee JK; Kim GI; Park Y; Chi YH; Paik SH; Lee JH; Lee KT
Bioorg Med Chem Lett; 2011 Nov; 21(21):6236-41. PubMed ID: 21963305
[TBL] [Abstract][Full Text] [Related]
13. A review of angiogenesis and anti-angiogenic therapy in hematologic malignancies.
Rajkumar SV; Mesa RA; Tefferi A
J Hematother Stem Cell Res; 2002 Feb; 11(1):33-47. PubMed ID: 11847002
[TBL] [Abstract][Full Text] [Related]
14. [Targeting angiogenesis in oncology].
Fayette J; Soria JC; Armand JP
Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
[TBL] [Abstract][Full Text] [Related]
15. [Intracellular mechanisms involved in the angiogenic process in hematological malignancies].
Barbarroja N; Velasco F; López-Pedrera C
Med Clin (Barc); 2008 Apr; 130(15):585-90. PubMed ID: 18462638
[TBL] [Abstract][Full Text] [Related]
16. The VEGF pathway in cancer and disease: responses, resistance, and the path forward.
Kieran MW; Kalluri R; Cho YJ
Cold Spring Harb Perspect Med; 2012 Dec; 2(12):a006593. PubMed ID: 23209176
[TBL] [Abstract][Full Text] [Related]
17. Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.
López-Pedrera C; Barbarroja N; Dorado G; Siendones E; Velasco F
Leukemia; 2006 Aug; 20(8):1331-40. PubMed ID: 16728982
[TBL] [Abstract][Full Text] [Related]
18. VEGF/VEGFR signalling as a target for inhibiting angiogenesis.
Kiselyov A; Balakin KV; Tkachenko SE
Expert Opin Investig Drugs; 2007 Jan; 16(1):83-107. PubMed ID: 17155856
[TBL] [Abstract][Full Text] [Related]
19. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
20. Novel angiogenesis inhibitors: addressing the issue of redundancy in the angiogenic signaling pathway.
Ribatti D
Cancer Treat Rev; 2011 Aug; 37(5):344-52. PubMed ID: 21435792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
